Next Article in Journal
Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study
Next Article in Special Issue
Zebrafish as an Innovative Tool for Epilepsy Modeling: State of the Art and Potential Future Directions
Previous Article in Journal
Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis
Previous Article in Special Issue
Exercise-Induced Fibroblast Growth Factor-21: A Systematic Review and Meta-Analysis
 
 
Article
Peer-Review Record

Otilonium Bromide Prevents Cholinergic Changes in the Distal Colon Induced by Chronic Water Avoidance Stress, a Rat Model of Irritable Bowel Syndrome

Int. J. Mol. Sci. 2023, 24(8), 7440; https://doi.org/10.3390/ijms24087440
by Chiara Traini 1,†, Eglantina Idrizaj 2,†, Cristina Biagioni 1, Maria Caterina Baccari 2 and Maria Giuliana Vannucchi 1,*
Reviewer 1:
Reviewer 2:
Int. J. Mol. Sci. 2023, 24(8), 7440; https://doi.org/10.3390/ijms24087440
Submission received: 24 March 2023 / Revised: 12 April 2023 / Accepted: 13 April 2023 / Published: 18 April 2023

Round 1

Reviewer 1 Report

Thank you for the review invitation. I enjoyed reading “Otilonium bromide prevents cholinergic changes in the distal colon induced by chronic water avoidance stress, a rat model of irritable bowel syndrome” by Traini et al. In this study an animal model for irritable bowel syndrome is used in rats. The authors compared the use of otilonium bromide to a control group in rats with repeated water avoidance stress. Increased chemical and contractile responses were seen, and were reduced by otilonium bromide administration. This is a relevant topic, as irritable bowel syndrome has a huge disease burden in human.

There are a few issues that need to be solved:

1. What was done with animals that were ill or died? Were they replaced?

2. How was the sample size achieved?

3. Section 4. 1 is not completely clear.

Why male rats?

How were they randomly divided?

May details are missing on handling of the animals. Perhaps a protocol should be included.

4. In the discussion or conclusion section, please make a suggestion for future research.

Author Response

Please, see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

Otilonium bromide (OB) is a medication used to treat irritable bowel syndrome (IBS). OB is a selective antispasmodic that acts directly on the colon, and it has the following pharmacological effects:

Antispasmodic effect: OB increases local blood flow in the colon and promotes muscle relaxation by inhibiting the release of acetylcholine (ACh), a neurotransmitter. This has the effect of relieving muscle spasms in the colon.

Antisecretory effect: OB inhibits mucus secretion in the colon, improving symptoms such as constipation.

Anti-inflammatory effect: OB has an anti-inflammatory effect in the colon.

Antibacterial effect: OB maintains the balance of bacteria in the colon by inhibiting the proliferation of bacteria.

Antimicrobial effect: OB has an effect similar to antibiotics against bacteria in the colon, inhibiting the growth of bacteria.

Therefore, since OB acts on various aspects of IBS symptoms and is used as a medication to improve IBS symptoms, it is recommended to provide sufficient descriptions of the research results known as previous studies on OB.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop